AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
POLYAMINE POOLS IN HIV-INFECTED CELLS
Authors: WHITE EL ROSE LM ALLAN PW BUCKHEIT RW SHANNON WM SECRIST JA
Citation: El. White et al., POLYAMINE POOLS IN HIV-INFECTED CELLS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(2), 1998, pp. 101-103
IN-VITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF THE CHROMANONE DERIVATIVE, 12-OXOCALANOLIDE-A, A NOVEL NNRTI
Authors: XU ZQ BUCKHEIT RW STUP TL FLAVIN MT KHILEVICH A RIZZO JD LIN L ZEMBOWER DE
Citation: Zq. Xu et al., IN-VITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF THE CHROMANONE DERIVATIVE, 12-OXOCALANOLIDE-A, A NOVEL NNRTI, Bioorganic & medicinal chemistry letters, 8(16), 1998, pp. 2179-2184
INHIBITION OF ACUTE-PHASE, LATENT-PHASE, AND CHRONIC-PHASE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY A BISTRIAZOLOACRIDONEANALOG THAT SELECTIVELY INHIBITS HIV-1 TRANSCRIPTION
Authors: TURPIN JA BUCKHEIT RW DERSE D HOLLINGSHEAD M WILLIAMSON K PALAMONE C OSTERLING MC HILL SA GRAHAM L SCHAEFFER CA BU M HUANG MJ CHOLODY WM MICHEJDA CJ RICE WG
Citation: Ja. Turpin et al., INHIBITION OF ACUTE-PHASE, LATENT-PHASE, AND CHRONIC-PHASE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY A BISTRIAZOLOACRIDONEANALOG THAT SELECTIVELY INHIBITS HIV-1 TRANSCRIPTION, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 487-494
INHIBITION OF IN-VITRO AND IN-VIVO HIV REPLICATION BY A DISTAMYCIN ANALOG THAT INTERFERES WITH CHEMOKINE RECEPTOR FUNCTION - A CANDIDATE FOR CHEMOTHERAPEUTIC AND MICROBICIDAL APPLICATION
Authors: HOWARD OMZ OPPENHEIM JJ HOLLINGSHEAD MG COVEY JM BIGELOW J MCCORMACK JJ BUCKHEIT RW CLANTON DJ TURPIN JA RICE WG
Citation: Omz. Howard et al., INHIBITION OF IN-VITRO AND IN-VIVO HIV REPLICATION BY A DISTAMYCIN ANALOG THAT INTERFERES WITH CHEMOKINE RECEPTOR FUNCTION - A CANDIDATE FOR CHEMOTHERAPEUTIC AND MICROBICIDAL APPLICATION, Journal of medicinal chemistry, 41(13), 1998, pp. 2184-2193
NEW ALKENYLDIARYLMETHANES WITH ENHANCED POTENCIES AS ANTI-HIV AGENTS WHICH ACT AS NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
Authors: CUSHMAN M CASIMIROGARCIA A HEJCHMAN E RUELL JA HUANG MJ SCHAEFFER CA WILLIAMSON K RICE WG BUCKHEIT RW
Citation: M. Cushman et al., NEW ALKENYLDIARYLMETHANES WITH ENHANCED POTENCIES AS ANTI-HIV AGENTS WHICH ACT AS NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Journal of medicinal chemistry, 41(12), 1998, pp. 2076-2089
ISOLATION AND CHARACTERIZATION OF ADOCIAVIRIN, A NOVEL HIV-INHIBITORYPROTEIN FROM THE SPONGE ADOCIA SP
Authors: OKEEFE BR ERIM T BEUTLER JA CARDELLINA JH GULAKOWSKI RJ KREPPS BL MCMAHON JB SOWDER RC JOHNSON DG BUCKHEIT RW HALLIDAY S BOYD MR
Citation: Br. Okeefe et al., ISOLATION AND CHARACTERIZATION OF ADOCIAVIRIN, A NOVEL HIV-INHIBITORYPROTEIN FROM THE SPONGE ADOCIA SP, FEBS letters, 431(1), 1998, pp. 85-90
AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN
Authors: RICE WG TURPIN JA HUANG MJ CLANTON D BUCKHEIT RW COVELL DG WALLQVIST A MCDONNELL NB DEGUZMAN RN SUMMERS MF ZALKOW L BADER JP HAUGWITZ RD SAUSVILLE EA
Citation: Wg. Rice et al., AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN, Nature medicine, 3(3), 1997, pp. 341-345
2'-FLUORO-2',3'-DIDEOXYARABINOSYLADENINE (F-DDA) - ACTIVITY AGAINST DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS AND CLADES A-E
Authors: DRISCOLL JS MAYERS DL BADER JP WEISLOW OS JOHNS DG BUCKHEIT RW
Citation: Js. Driscoll et al., 2'-FLUORO-2',3'-DIDEOXYARABINOSYLADENINE (F-DDA) - ACTIVITY AGAINST DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS AND CLADES A-E, Antiviral chemistry & chemotherapy, 8(2), 1997, pp. 107-111
EFFICACY, PHARMACOKINETICS, AND IN-VIVO ANTIVIRAL ACTIVITY OF UC781, A HIGHLY POTENT, ORALLY BIOAVAILABLE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HIV TYPE-1
Authors: BUCKHEIT RW HOLLINGSHEAD M SINSON S FLIAKASBOLTZ V PALLANSCH LA ROBERSON J DECKER W ELDER C BORGEL S BONOMI C SHORES R SIFORD T MALSPEIS L BADER JP
Citation: Rw. Buckheit et al., EFFICACY, PHARMACOKINETICS, AND IN-VIVO ANTIVIRAL ACTIVITY OF UC781, A HIGHLY POTENT, ORALLY BIOAVAILABLE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HIV TYPE-1, AIDS research and human retroviruses, 13(9), 1997, pp. 789-796
THE ROLE OF HYDROPHOBIC VERSUS HYDROPHILIC BASE CHARACTER IN THE ANTI-HIV ACTIVITY OF PURINE-CONTAINING POLYRIBONUCLEOTIDES
Authors: TUTONDA MG FAIN HD BUCKHEIT RW BROOM AD
Citation: Mg. Tutonda et al., THE ROLE OF HYDROPHOBIC VERSUS HYDROPHILIC BASE CHARACTER IN THE ANTI-HIV ACTIVITY OF PURINE-CONTAINING POLYRIBONUCLEOTIDES, Nucleosides & nucleotides, 16(1-2), 1997, pp. 173-182
MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE DRUG-RESISTANT MUTANT STRAINS - IMPLICATIONS FOR THE MECHANISM OF POLYMERASE ACTION
Authors: SMITH MBK MICHEJDA CJ HUGHES SH BOYER PL JANSSEN PAJ ANDRIES K BUCKHEIT RW SMITH RH
Citation: Mbk. Smith et al., MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE DRUG-RESISTANT MUTANT STRAINS - IMPLICATIONS FOR THE MECHANISM OF POLYMERASE ACTION, Protein engineering, 10(12), 1997, pp. 1379-1383
ANTIREPLICATIVE AND ANTICYTOPATHIC ACTIVITIES OF PROSTRATIN, A NON-TUMOR-PROMOTING PHORBOL ESTER, AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
Authors: GULAKOWSKI RJ MCMAHON JB BUCKHEIT RW GUSTAFSON KR BOYD MR
Citation: Rj. Gulakowski et al., ANTIREPLICATIVE AND ANTICYTOPATHIC ACTIVITIES OF PROSTRATIN, A NON-TUMOR-PROMOTING PHORBOL ESTER, AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV), Antiviral research, 33(2), 1997, pp. 87-97
THE ROLE OF GENOTYPIC HETEROGENEITY IN WILD-TYPE VIRUS POPULATIONS ONTHE SELECTION OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUSES
Authors: KINJERSKI TL BUCKHEIT RW
Citation: Tl. Kinjerski et Rw. Buckheit, THE ROLE OF GENOTYPIC HETEROGENEITY IN WILD-TYPE VIRUS POPULATIONS ONTHE SELECTION OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUSES, Antiviral research, 33(2), 1997, pp. 109-115
DISCOVERY OF CYANOVIRIN-N, A NOVEL HUMAN IMMUNODEFICIENCY VIRUS-INACTIVATING PROTEIN THAT BINDS VIRAL SURFACE ENVELOPE GLYCOPROTEIN GP120 -POTENTIAL APPLICATIONS TO MICROBICIDE DEVELOPMENT
Authors: BOYD MR GUSTAFSON KR MCMAHON JB SHOEMAKER RH OKEEFE BR MORI T GULAKOWSKI RJ WU L RIVERA MI LAURENCOT CM CURRENS MJ CARDELLINA JH BUCKHEIT RW NARA PL PANNELL LK SOWDER RC HENDERSON LE
Citation: Mr. Boyd et al., DISCOVERY OF CYANOVIRIN-N, A NOVEL HUMAN IMMUNODEFICIENCY VIRUS-INACTIVATING PROTEIN THAT BINDS VIRAL SURFACE ENVELOPE GLYCOPROTEIN GP120 -POTENTIAL APPLICATIONS TO MICROBICIDE DEVELOPMENT, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1521-1530
HIGHLY POTENT OXATHIIN CARBOXANILIDE DERIVATIVES WITH EFFICACY AGAINST NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES
Authors: BUCKHEIT RW SNOW MJ FLIAKASBOLTZ V KINJERSKI TL RUSSELL JD PALLANSCH LA BROUWER WG YANG SS
Citation: Rw. Buckheit et al., HIGHLY POTENT OXATHIIN CARBOXANILIDE DERIVATIVES WITH EFFICACY AGAINST NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 831-837
INHIBITION OF MULTIPLE PHASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A DITHIANE COMPOUND THAT ATTACKS THE CONSERVED ZINC FINGERS OF RETROVIRAL NUCLEOCAPSID PROTEINS
Authors: RICE WG BAKER DC SCHAEFFER CA GRAHAM L BU M TERPENING S CLANTON D SCHULTZ R BADER JP BUCKHEIT RW FIELD L SINGH PK TURPIN JA
Citation: Wg. Rice et al., INHIBITION OF MULTIPLE PHASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A DITHIANE COMPOUND THAT ATTACKS THE CONSERVED ZINC FINGERS OF RETROVIRAL NUCLEOCAPSID PROTEINS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 419-426
STRUCTURAL ANALOGS OF THE CALANOLIDE ANTI-HIV AGENTS - MODIFICATION OF THE TRANS-10,11-DIMETHYLDIHYDROPYRAN-12-OL RING (RING-C)
Authors: ZEMBOWER DE LIAO SY FLAVIN MT XU ZQ STUP TL BUCKHEIT RW KHILEVICH A MAR AA SHEINKMAN AK
Citation: De. Zembower et al., STRUCTURAL ANALOGS OF THE CALANOLIDE ANTI-HIV AGENTS - MODIFICATION OF THE TRANS-10,11-DIMETHYLDIHYDROPYRAN-12-OL RING (RING-C), Journal of medicinal chemistry, 40(6), 1997, pp. 1005-1017
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE - 2-ARYL-SUBSTITUTED BENZIMIDAZOLES
Authors: ROTH T MORNINGSTAR ML BOYER PL HUGHES SH BUCKHEIT RW MICHEJDA CJ
Citation: T. Roth et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE - 2-ARYL-SUBSTITUTED BENZIMIDAZOLES, Journal of medicinal chemistry, 40(26), 1997, pp. 4199-4207
A DIARYLSULPHONE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR WITH AUNIQUE SENSITIVITY PROFILE TO DRUG-RESISTANT VIRUS ISOLATES
Authors: BUCKHEIT RW FLIAKASBOLTZ V RUSSELL JD SNOW M PALLANSCH LA YANG SS BADER JP KHAN TN ZANGER M
Citation: Rw. Buckheit et al., A DIARYLSULPHONE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR WITH AUNIQUE SENSITIVITY PROFILE TO DRUG-RESISTANT VIRUS ISOLATES, Antiviral chemistry & chemotherapy, 7(5), 1996, pp. 243-252
ISOLATION AND CHARACTERIZATION OF HIV-1 ISOLATES RESISTANT TO OXATHIIN CARBOXANILIDE ANALOGS - EVALUATION OF VARIABLES IN THE DRUG-RESISTANCE SELECTION PROCESS
Authors: KINJERSKI TL PALLANSCH LA BUCKHEIT RW
Citation: Tl. Kinjerski et al., ISOLATION AND CHARACTERIZATION OF HIV-1 ISOLATES RESISTANT TO OXATHIIN CARBOXANILIDE ANALOGS - EVALUATION OF VARIABLES IN THE DRUG-RESISTANCE SELECTION PROCESS, Antiviral chemistry & chemotherapy, 7(5), 1996, pp. 261-269
INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY THE SULFONATED STILBENE DYE RESOBENE
Authors: HALLIDAY SM LACKMANSMITH C BADER JP RICE WG CLANTON DJ ZALKOW LH BUCKHEIT RW
Citation: Sm. Halliday et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY THE SULFONATED STILBENE DYE RESOBENE, Antiviral research, 33(1), 1996, pp. 41-53
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION IS UNAFFECTEDBY HUMAN SECRETORY LEUKOCYTE PROTEASE INHIBITOR
Authors: TURPIN JA SCHAEFFER CA BU M GRAHAM L BUCKHEIT RW CLANTON D RICE WG
Citation: Ja. Turpin et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION IS UNAFFECTEDBY HUMAN SECRETORY LEUKOCYTE PROTEASE INHIBITOR, Antiviral research, 29(2-3), 1996, pp. 269-277
ANTIVIRAL ACTIVITY AND MECHANISM OF ACTION OF CALANOLIDE-A AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: CURRENS MJ GULAKOWSKI RJ MARINER JM MORAN RA BUCKHEIT RW GUSTAFSON KR MCMAHON JB BOYD MR
Citation: Mj. Currens et al., ANTIVIRAL ACTIVITY AND MECHANISM OF ACTION OF CALANOLIDE-A AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 645-651
BIOLOGICAL AND BIOCHEMICAL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITYOF UC-38, A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: MCMAHON JB BUCKHEIT RW GULAKOWSKI RJ CURRENS MJ VISTICA DT SHOEMAKER RH STINSON SF RUSSELL JD BADER JP NARAYANAN VL SCHULTZ RJ BROUWER WG FELAUER EE BOYD MR
Citation: Jb. Mcmahon et al., BIOLOGICAL AND BIOCHEMICAL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITYOF UC-38, A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 298-305
EVALUATION OF SELECTED CHEMOTYPES IN COUPLED CELLULAR AND MOLECULAR TARGET-BASED SCREENS IDENTIFIES NOVEL HIV-1 ZINC-FINGER INHIBITORS
Authors: RICE WG TURPIN JA SCHAEFFER CA GRAHAM L CLANTON D BUCKHEIT RW ZAHAREVITZ D SUMMERS MF WALLQVIST A COVELL DG
Citation: Wg. Rice et al., EVALUATION OF SELECTED CHEMOTYPES IN COUPLED CELLULAR AND MOLECULAR TARGET-BASED SCREENS IDENTIFIES NOVEL HIV-1 ZINC-FINGER INHIBITORS, Journal of medicinal chemistry, 39(19), 1996, pp. 3606-3616
Risultati: 1-25 | 26-50 | 51-54